Medpace Holdings, Inc.
Simbols: MEDP
NASDAQ
392.57
USDTirgus cena šodien
38.7448
P/E koeficients
0.0000
PEG koeficients
12.16B
MRK Cap
- 0.00%
DIV ienesīgums
Medpace Holdings, Inc. (MEDP) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 1145.4 | 298.4 | 253.4 | 186.4 | ||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-current-assets | 234.34 | 50 | 52.3 | 43.2 | ||||||||||
balance-sheet.row.total-current-assets | 2166.54 | 593.8 | 334 | 690.9 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 1036.38 | 265.4 | 248.9 | 222.7 | ||||||||||
balance-sheet.row.goodwill | 2649.58 | 662.4 | 662.4 | 662.4 | ||||||||||
balance-sheet.row.intangible-assets | 144.52 | 35.8 | 38 | 41.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2794.11 | 698.2 | 700.4 | 703.8 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.tax-assets | 260.77 | 74.4 | 48.1 | 25.1 | ||||||||||
balance-sheet.row.other-non-current-assets | 88.47 | 25 | 21.1 | 17.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 4179.74 | 1063 | 1018.5 | 969 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.account-payables | 118.9 | 31.9 | 33.1 | 25.7 | ||||||||||
balance-sheet.row.short-term-debt | 885.06 | 293 | 50 | 159.3 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 6.99 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 392.9 | 40.4 | 257.7 | 27.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 671.08 | 172.7 | 162.6 | 149.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
balance-sheet.row.total-liab | 4253.81 | 1097.9 | 966.1 | 707 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 1.23 | 0.3 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.retained-earnings | -1012 | -221.6 | -359.8 | 235 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -46.18 | -10.1 | -12.4 | -4.8 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 3149.41 | 790.4 | 758.3 | 722.4 | ||||||||||
balance-sheet.row.total-stockholders-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6346.28 | - | - | - | ||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-debt | 615.71 | 142.1 | 188.9 | 131 | ||||||||||
balance-sheet.row.net-debt | -171.1 | -103.3 | 160.6 | -330.3 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 | ||||||||||
cash-flows.row.depreciation-and-amortization | 27.36 | 26.3 | 22.3 | 21.1 | ||||||||||
cash-flows.row.deferred-income-tax | -24.92 | -25.1 | -23 | -37.1 | ||||||||||
cash-flows.row.stock-based-compensation | 19.39 | 20.5 | 21.4 | 14.5 | ||||||||||
cash-flows.row.change-in-working-capital | 151.12 | 106.5 | 106.1 | 66.7 | ||||||||||
cash-flows.row.account-receivables | -24.82 | -48.3 | -66.9 | -25 | ||||||||||
cash-flows.row.inventory | 43.94 | 66.2 | 0 | 25 | ||||||||||
cash-flows.row.account-payables | -10.76 | 1.1 | 6.4 | 1.9 | ||||||||||
cash-flows.row.other-working-capital | 179.05 | 87.5 | 166.5 | 64.8 | ||||||||||
cash-flows.row.other-non-cash-items | 20.52 | 22.4 | 15.9 | 16.3 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 505.98 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 10.04 | 2 | -1.9 | -3.1 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.6 | -34.6 | -38.7 | -31.4 | ||||||||||
cash-flows.row.debt-repayment | -130 | -155 | -274.2 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 16.57 | 11.4 | 22.1 | 17.6 | ||||||||||
cash-flows.row.common-stock-repurchased | -23.87 | -144 | -847.8 | -62.1 | ||||||||||
cash-flows.row.dividends-paid | 0 | -11.4 | -22.1 | 0 | ||||||||||
cash-flows.row.other-financing-activites | -23.43 | 116.4 | 346.3 | -44.5 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.3 | -182.6 | -775.8 | -44.5 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.99 | 1.1 | -6.6 | -4 | ||||||||||
cash-flows.row.net-change-in-cash | 360.09 | 217.2 | -433 | 183.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 426.72 | 28.3 | 461.3 | 277.8 | ||||||||||
cash-flows.row.operating-cash-flow | 505.98 | 433.4 | 388.1 | 263.3 | ||||||||||
cash-flows.row.capital-expenditure | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.free-cash-flow | 473.34 | 396.7 | 351.2 | 235.1 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1962.81 | 1885.8 | 1460 | 1142.4 | ||||||||||
income-statement-row.row.cost-of-revenue | 1413.35 | 1361.3 | 1027.6 | 814.2 | ||||||||||
income-statement-row.row.gross-profit | 549.46 | 524.5 | 432.4 | 328.2 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 41.01 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.operating-expenses | 194.77 | 187.7 | 153.7 | 129.5 | ||||||||||
income-statement-row.row.cost-and-expenses | 1608.12 | 1549 | 1181.3 | 943.8 | ||||||||||
income-statement-row.row.interest-income | 3.31 | 0 | 2.9 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 26.08 | 26.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.ebitda-caps | 381.37 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 354.69 | 336.8 | 278.7 | 198.6 | ||||||||||
income-statement-row.row.income-before-tax | 362.43 | 335.7 | 282.9 | 201.9 | ||||||||||
income-statement-row.row.income-tax-expense | 49.93 | 52.9 | 37.5 | 20 | ||||||||||
income-statement-row.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 |
Biežāk uzdotie jautājumi
Kas ir Medpace Holdings, Inc. (MEDP) kopējie aktīvi?
Medpace Holdings, Inc. (MEDP) kopējie aktīvi ir 1656828000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 1009445000.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.280.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 15.347.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.159.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.181.
Kāda ir Medpace Holdings, Inc. (MEDP) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 282810000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 142122000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 187680000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 407010000.000.